Johnson & Johnson
Garnet Valley, Pennsylvania, United States
Strategic pharmaceutical professional with 8 years of industry experience, focused on autoimmune diseases, including SLE, lupus nephritis, and rare maternal-fetal immunology. Proven track record in building and managing relationships with KOLs in these areas, fostering external collaborations, and facilitating cross-functional initiatives to advance clinical research. Adept in clinical trial planning and design from Phase 1 to Phase 3, leading biomarker strategies and authoring clinical reports that drive understanding of disease mechanisms and treatment efficacy. Currently, developing within the Global Medical Affairs team enhancing strategic alignments and effectively engaging with internal and external stakeholders for the advancement of innovative therapeutic approaches for lupus and maternal-fetal immunolgy. Proactive leader dedicated to advancing health equity and enhancing diversity within clinical trials and rheumatology research.
Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): Johnson & Johnson: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
